bioAffinity Technologies, Inc. (BIAF) Q3 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the BioAffinity Technologies Third Quarter 2022 Business Update and Financial Results Conference Call. I will now turn the call over to Jonathan Nugent, Investor Relations for BioAffinity. Thank you. Please go ahead. Thank you, Operator. Good morning, everyone, and thank you for joining the call. With me today is BioAffinity's President and Chief Executive Officer, Maria Zanes, who will provide an update of the company's recent business activity, and Michael Edwards, the company's chief financial officer, who will provide more detail on the company's financial results. Earlier this morning, BioAffinity issued a press release detailing business activity for the third quarter ended September 30, 2022. BioAffinity encourages listeners to review the press release, which is available on the company's website at www.bioaffinitytech.com. This call is being recorded and replay will be available on the investor section of the BioAffinity website for approximately 45 days. This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties. The company may, in some cases, use terms such as predict, believe, potential, proposed, continue, estimate, anticipate, expect, plan, intend, may, could, might, will, should, or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such forward-looking statements include, but are not limited to, statements about the company's programs and the potential for side path launch. Such statements are subject to numerous important factors, risks, and uncertainties, and may cause actual events or results to differ materially from the company's current expect...